{"url_path":"/sec/rpid/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1380106/0001380106-26-000075-index.html","accession_number":"0001380106-26-000075","cik":"0001380106","ticker":"RPID","issuer_name":"RAPID MICRO BIOSYSTEMS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1380106/0001380106-26-000075-index.html","primary_entity_key":"0001380106","primary_entity_name":"RAPID MICRO BIOSYSTEMS, INC."},"word_count":84,"has_tables":true,"body_markdown":"Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities\n\nRecent Sales of Unregistered Securities; Purchases of Equity Securities by the Issuer or Affiliated Purchaser\n\nNone.\n\nUse of Proceeds\n\nOn July 14, 2021, the Registration Statement on Form S-1 (File No. 333-257431) relating to our initial public offering (\"IPO\") was declared effective by the SEC. There has been no material change in the expected use of the net proceeds from our IPO as described in our final prospectus."}